Back to today’s briefing

Story perspectives

CVS Health Surges 40% Despite Q4 Earnings Disappointment

2/10/2026

46 9 Full Breakdown

Summary

Story summary

CVS Health reported strong fourth-quarter 2025 earnings with revenue of $105.7 billion.
Adjusted earnings per share reached $1.09, up from $1.30 a year prior.
The company reaffirmed its 2026 profit guidance of $7 to $7.20 per share, disappointing investors.
Rising medical costs and a decline in Medicare Advantage enrollment pose challenges.
CVS’s stock has risen 40% over the past year under CEO David Joyner.

History

Historical Context

The Affordable Care Act, enacted in 2010, expanded healthcare access, significantly benefiting companies like CVS Health. By 2025, CVS reported $105.7 billion in revenue, reflecting ongoing changes in the healthcare market. However, challenges such as rising medical costs and declining Medicare Advantage enrollment echo historical concerns about healthcare sustainability, influencing future policies and corporate strategies in the industry.

1 of 2

Story summary

CVS Health reported strong fourth-quarter 2025 earnings with revenue of $105.7 billion.
Adjusted earnings per share reached $1.09, up from $1.30 a year prior.
The company reaffirmed its 2026 profit guidance of $7 to $7.20 per share, disappointing investors.
Rising medical costs and a decline in Medicare Advantage enrollment pose challenges.
CVS’s stock has risen 40% over the past year under CEO David Joyner.

1 / 2